Owner only: item control page
Kreft, Sophia ; Glutsch, Valerie ; Zaremba, Anne ; Schummer, Patrick 
; Mohr, Peter ; Grimmelmann, Imke ; Gutzmer, Ralf ; Meier, Friedegund ; Pföhler, Claudia ; Sachse, Michael Max ; Meiss, Frank ; Forschner, Andrea ; Haferkamp, Sebastian ; Welzel, Julia ; Terheyden, Patrick ; Herbst, Rudolf ; Utikal, Jochen ; Kaatz, Martin ; Weishaupt, Carsten ; Kreuter, Alexander ; Debus, Dirk ; Duecker, Pia ; Sindrilaru, Anca ; Löffler, Harald ; Schley, Gaston ; Weichenthal, Michael ; Schadendorf, Dirk ; Ugurel, Selma ; Gesierich, Anja ; Schilling, Bastian
; Mohr, Peter ; Grimmelmann, Imke ; Gutzmer, Ralf ; Meier, Friedegund ; Pföhler, Claudia ; Sachse, Michael Max ; Meiss, Frank ; Forschner, Andrea ; Haferkamp, Sebastian ; Welzel, Julia ; Terheyden, Patrick ; Herbst, Rudolf ; Utikal, Jochen ; Kaatz, Martin ; Weishaupt, Carsten ; Kreuter, Alexander ; Debus, Dirk ; Duecker, Pia ; Sindrilaru, Anca ; Löffler, Harald ; Schley, Gaston ; Weichenthal, Michael ; Schadendorf, Dirk ; Ugurel, Selma ; Gesierich, Anja ; Schilling, Bastian MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG
Kreft, Sophia, Glutsch, Valerie, Zaremba, Anne, Schummer, Patrick, Mohr, Peter, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund , Pföhler, Claudia, Sachse, Michael Max, Meiss, Frank, Forschner, Andrea, Haferkamp, Sebastian, Welzel, Julia, Terheyden, Patrick, Herbst, Rudolf, Utikal, Jochen, Kaatz, Martin, Weishaupt, Carsten, Kreuter, Alexander, Debus, Dirk, Duecker, Pia, Sindrilaru, Anca, Löffler, Harald, Schley, Gaston, Weichenthal, Michael, Schadendorf, Dirk, Ugurel, Selma, Gesierich, Anja and Schilling, Bastian
(2022)
MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma – An evaluation of the multicenter prospective skin cancer registry ADOREG.
European Journal of Cancer 167, pp. 32-41.
Date of publication of this fulltext: 29 Feb 2024 13:02
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Journal of Cancer | ||||
| Publisher: | Elsevier | ||||
|---|---|---|---|---|---|
| Place of Publication: | OXFORD | ||||
| Volume: | 167 | ||||
| Page Range: | pp. 32-41 | ||||
| Date | 2022 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie | ||||
| Identification Number |
| ||||
| Keywords | DABRAFENIB PLUS TRAMETINIB; SURVIVAL; EFFICACY; Melanoma; PD-1 resistance; MAPK; Second-line treatment; Third-line treatment | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 57746 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric